Vanguard Health Care ETF (VHT)
150.41
+0.06 +0.04%
NYSE Arca
Jun 23, 20:00
Delayed 2m
USD
VHT Key Stats
| Expense Ratio | 0.10% |
| Share Class Assets Under Management | 6.749B |
| 30-Day Average Daily Volume | Upgrade |
| Net Asset Value | 150.31 |
| Discount or Premium to NAV | 0.07% |
| Turnover Ratio | 7.00 |
View All VHT News
VHT News
-
WireHeadlineTime (ET)
-
MT Newswires06/23 13:25
-
Yahoo06/23 10:04
-
MT Newswires06/23 09:19
-
Yahoo06/22 21:35
-
MT Newswires06/22 13:14
-
MT Newswires06/22 09:22
-
MT Newswires06/21 13:17
-
MT Newswires06/21 09:22
-
Yahoo06/21 09:08
-
Yahoo06/20 14:06
VHT Performance
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | 7.47% | 7.50% | 35 |
| 3M | 9.74% | 10.30% | 59 |
| 6M | 17.98% | 19.13% | 60 |
| 1Y | 17.02% | 19.30% | 54 |
| 3Y | 12.12% | 10.02% | 25 |
| 5Y | 18.90% | 18.23% | 51 |
Returns for periods of 1 year and above are annualized.
VHT Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.39% | 0.39% | 0.00 |
| Stock | 99.61% | 99.61% | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Convertible | 0.00 | 0.00 | 0.00 |
| Preferred | 0.00 | 0.00 | 0.00 |
| Other | 0.01% | 0.01% | 0.00 |
VHT Region Exposure
| Americas | 99.88% |
| North America | 99.87% |
| Latin America | 0.01% |
| Greater Europe | 0.11% |
| United Kingdom | 0.07% |
| Europe Developed | 0.04% |
| Europe Emerging | 0.00 |
| Africa/Middle East | 0.00 |
| Greater Asia | 0.01% |
| Japan | 0.00 |
| Australasia | 0.00 |
| Asia Developed | 0.01% |
| Asia Emerging | 0.00 |
| Market Classification | |
| % Developed Markets | 100.00% |
| % Emerging Markets | 0.00 |
Region breakdown data is calculated by using the long position holdings of the portfolio.
VHT Stock Sector Exposure
| Basic Materials | 0.00 |
| Communication Services | 0.00 |
| Consumer Cyclical | 0.00 |
| Consumer Defensive | 0.00 |
| Energy | 0.00 |
| Financial Services | 0.03% |
| Healthcare | 98.43% |
| Industrials | 0.06% |
| Real Estate | 0.00 |
| Technology | 1.49% |
| Utilities | 0.00 |
VHT Stock Market Capitalization
| Giant | 41.77% |
| Large | 36.73% |
| Medium | 13.46% |
| Small | 5.43% |
| Micro | 2.61% |
VHT Stock Style Exposure
| Large Cap Value | 26.78% |
| Large Cap Blend | 23.53% |
| Large Cap Growth | 28.55% |
| Mid Cap Value | 1.70% |
| Mid Cap Blend | 3.31% |
| Mid Cap Growth | 8.51% |
| Small Cap Value | 0.52% |
| Small Cap Blend | 1.90% |
| Small Cap Growth | 5.20% |
View More Holdings
As of May 31, 2017
VHT Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 10.31% | 136.43 | +0.28% |
| PFE | Pfizer Inc | 5.75% | 34.17 | +0.32% |
| MRK | Merck & Co Inc | 5.32% | 66.16 | +0.21% |
| UNH | UnitedHealth Group Inc | 4.99% | 185.25 | -0.67% |
| MDT | Medtronic PLC | 3.43% | 89.20 | +0.12% |
| AMGN | Amgen Inc | 3.39% | 172.50 | -0.76% |
| ABBV | AbbVie Inc | 3.12% | 72.64 | -0.74% |
| BMY | Bristol-Myers Squibb Company | 2.67% | 56.64 | -1.20% |
| CELG | Celgene Corp | 2.64% | 134.31 | +0.47% |
| GILD | Gilead Sciences Inc | 2.51% | 70.52 | +0.06% |
Advertisement
VHT Ratings
| Fiduciary Score | Upgrade |
VHT One Page Reports
- One Page Report Download
VHT Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Vanguard |
| Benchmark Index | |
|---|---|
MSCI US IMI/Health Care 25-50 GR USD |
100.0% |
VHT Manager Info
| Name | Tenure |
|---|---|
| Scott Geiger | 1.36 yrs |
| Walter Nejman | 1.36 yrs |
VHT Net Fund Flows
| 1M | 12.56M |
| 3M | 153.97M |
| 6M | 175.10M |
| YTD | 183.61M |
| 1Y | 202.40M |
| 3Y | 2.525B |
| 5Y | 4.121B |
| 10Y | 4.379B |
VHT Risk Info
| Beta (5Y) | 0.9539 |
| Max Drawdown (All) | 40.83% |
| Historical Sharpe (10Y) | 0.7391 |
| Historical Sortino (All) | 0.8769 |
| 30-Day Rolling Volatility | 9.02% |
| Daily Value at Risk (VaR) 1% (All) | 2.91% |
| Monthly Value at Risk (VaR) 1% (All) | 13.11% |
VHT Fundamentals
| Dividend Yield TTM (6-23-17) | 1.26% |
| SEC Yield (6-23-17) | 1.43% |
| Weighted Average PE Ratio | 23.13 |
| Weighted Average Price to Sales Ratio | 1.814 |
| Weighted Average Price to Book Ratio | 3.775 |
| Weighted Median ROE | 18.90% |
| Weighted Median ROA | 6.04% |
| Forecasted Dividend Yield | 1.56% |
| Forecasted PE Ratio | 20.53 |
| Forecasted Price to Sales Ratio | 1.667 |
| Forecasted Price to Book Ratio | 3.242 |
| Number of Holdings | 366 |
VHT Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.50% |
| Forecasted Book Value Growth | 8.66% |
| Forecasted Cash Flow Growth | 14.36% |
| Forecasted Earnings Growth | 10.81% |
| Forecasted Revenue Growth | 9.75% |
VHT Comparables
EditVHT Attributes
| Key Dates | |
|---|---|
| Inception Date | 1/26/2004 |
| Last Annual Report Date | 8/31/2016 |
| Last Prospectus Date | 12/22/2016 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
VHT Excel Add-In Codes
- Name: =YCI("VHT","name")
- Broad Asset Class: =YCI("VHT", "broad_asset_class")
- Broad Category: =YCI("VHT", "broad_category_group")
- Prospectus Objective: =YCI("VHT", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
